Consistently, we found no correlation between the TAOK2 mRNA expression in human liver biopsies and the histological scores of NAFLD severity (i.e., NAS composed of individual scores of liver steatosis, lobular inflammation, and hepatocellular ballooning) or hepatic fibrosis (Fig. 8E–I). Here, TAOK2 is linked to metabolic dysfunction-associated steatotic liver disease.